enzalutamide

Drug Overview

Enzalutamide is a powerful, modern medicine used to treat prostate cancer. It is known as a Targeted Therapy and a “Smart Drug” because it specifically targets the signals that cancer cells use to grow. Unlike traditional chemotherapy, which affects the whole body, enzalutamide focuses on blocking the hormones that “feed” the tumor.

By interfering with the way cancer cells communicate, enzalutamide helps slow down the spread of the disease and can help patients live longer, even when other treatments have stopped working.

• Generic Name: Enzalutamide
• US Brand Names: Xtandi®
• Drug Class: Androgen Receptor Inhibitor (Second-generation anti-androgen)
• Route of Administration: Oral (Capsules or Tablets taken by mouth)
• FDA Approval Status: FDA-Approved

What Is It and How Does It Work? (Mechanism of Action)

Prostate cancer cells usually need male hormones, called androgens (like testosterone), to grow. You can think of testosterone as “fuel” and the cancer cell as an “engine.” For the engine to run, the fuel must attach to a “starter switch” called an Androgen Receptor.

Enzalutamide works by “clogging” that starter switch. It is much more advanced than older drugs because it blocks the process in three different ways:

1. Blocking the Attachment: It prevents testosterone from even touching the receptor. If the fuel can’t reach the switch, the engine can’t start.
2. Stopping the Movement: Even if a receptor is activated, enzalutamide stops that receptor from moving into the “control center” (the nucleus) of the cell.
3. Preventing DNA Binding: If the receptor manages to get into the control center, the drug stops it from touching the cell’s DNA. This prevents the cell from getting the “instruction” to make more cancer cells.

By stopping these three steps, the cancer cells starve and eventually die, causing the tumor to shrink.

FDA-Approved Clinical Indications

Enzalutamide is specifically approved for the treatment of various stages of prostate cancer:

Oncological uses:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC): For cancer that has spread to other parts of the body and no longer responds to treatments that lower testosterone.
• Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC): For cancer that has not spread yet but is resisting standard hormone therapy.
• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): For cancer that has spread but still responds to hormone therapy.

Non-oncological uses:

• There are currently no approved non-cancer uses for this medication.

Dosage and Administration Protocols

Enzalutamide is taken once a day, with or without food. It is important to take it at the same time every day to keep a steady amount of medicine in your blood.

Note: Capsules and tablets must be swallowed whole. Do not chew, dissolve, or open them.

Clinical Efficacy and Research Results

Recent clinical studies (2020–2025) have confirmed that enzalutamide is a leader in extending life for prostate cancer patients.

• Survival Rates: In large trials like the ARCHES and PROSPER studies, enzalutamide was shown to reduce the risk of the cancer getting worse or death by 33% to 71% depending on the stage of the disease.
• Disease Progression: Data from 2024 updates shows that patients taking enzalutamide can go significantly longer (often years longer) without their cancer spreading compared to those taking older hormone treatments.
• Quality of Life: Research indicates that this drug helps delay the need for painful chemotherapy, allowing patients to maintain their daily activities for a longer period.

Safety Profile and Side Effects

Enzalutamide is generally well-tolerated, but because it blocks hormones, it can cause specific side effects.

Important Warning: While there is no “Black Box Warning,” there is a known risk of Seizures (affecting about 0.5% of patients). Patients with a history of seizures or brain injury should discuss this with their doctor.

Common side effects (>10%):

• Fatigue: Feeling very tired or weak.
• Hot Flashes: Sudden feelings of warmth and sweating.
• Hypertension: High blood pressure.
• Back Pain/Joint Pain: General body aches.
• Decreased Appetite: Loss of interest in food.

Serious adverse events:

• Seizures: Sudden uncontrolled electrical disturbances in the brain.
• Falls and Fractures: Increased risk of falling and breaking bones.
• Ischemic Heart Disease: Blockages in the heart’s blood flow (in patients with existing heart risks).

Management Strategies: Fatigue is often managed by gentle exercise and planned rest. If blood pressure rises, your doctor may prescribe a blood pressure medication. If you feel dizzy or confused, contact your medical team immediately.

Research Areas

Current research into enzalutamide is looking at “Combination Therapy.” While enzalutamide is not a stem cell drug, scientists are testing it alongside Immunotherapy and PARP Inhibitors (another type of “Smart Drug”). The goal is to see if attacking the cancer from two different angles at once can prevent the cancer from ever becoming resistant to treatment.

Patient Management and Practical Recommendations

Pre-treatment tests to be performed:

• PSA Level: A blood test to measure a protein made by the prostate.
• Liver and Kidney Function: To ensure your body can process the drug.
• Blood Pressure: Establishing a “normal” baseline.

Precautions during treatment:

• Seizure Risk: Avoid activities where a sudden loss of consciousness could be dangerous (like swimming alone or certain driving).
• Drug Interactions: Enzalutamide reacts with many other drugs. Always show your doctor a full list of your medications.

“Do’s and Don’ts” list:

• DO take your medicine at the same time every day.
• DO use effective birth control (including a condom) if having sex with a woman who could get pregnant, as the drug can harm an unborn baby.
• DON’T crush or chew the tablets.
• DON’T stop taking the medicine without talking to your oncologist first.

Legal Disclaimer

This guide is for informational purposes only and does not constitute medical advice. Enzalutamide (Xtandi) is a prescription medication that must be used under the supervision of a licensed healthcare provider. Always consult with your doctor or oncologist regarding your specific diagnosis and treatment options. If you are experiencing a medical emergency, contact your local emergency services immediately.